Nico Choksi

Nico is COO at Epitel. Epitel is changing the way we diagnose and manage neurological disorders in-hospital and at home, starting with seizures. Nico was previously an investor at Unilever Ventures, focusing on enterprise technology, new commerce models, and consumer brands. He managed or worked on Unilever Ventures’ LP investments in Seedcamp and Cathay Innovation as well as direct investments in CreatorIQ, Grabango, Jellysmack, Zitsticka, WeGift, FabFitFun, and True Botanicals. Nico has helped set up a venture capital seed fund, invested with London-based seed fund Force Over Mass, and helped B2B and B2C start-ups raise VC funding. He was previously a healthcare consultant in DC and the Bay Area. Nico has an MBA from London Business School and is a former Fellow of the Ellen MacArthur Foundation.